Last week, we covered the biology behind variable semaglutide response — why genetics, hormones, sleep, stress, and dosing all shape your results, and why a limited response is never simply a matter of trying harder.

This week: what to actually do about it. Here's the systematic, evidence-based approach we use at Healthy You when semaglutide isn't delivering the results a patient deserves.

You started semaglutide with real hope. You'd heard about the clinical trials, seen the results in the news, maybe watched a friend drop thirty pounds with ease. So when the scale barely moves — or stalls entirely after a modest start — the disappointment can feel personal. Like your body is broken. Like you're doing something wrong.

You're not.

Polycystic ovary syndrome affects approximately 1 in 10 women of reproductive age. It is the most common endocrine disorder in women. It drives infertility, metabolic disease, type 2 diabetes, cardiovascular risk, anxiety, depression, and a relentless daily burden of symptoms — irregular periods, hair loss, acne, weight gain that doesn't respond to effort, and a medical system that often dismisses all of it. And yet, there is not a single FDA-approved medication specifically indicated for PCOS.

Not one.